Century Therapeutics
IPSC • NASDAQ • Stock Fundamentals
Century Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brent Pfeiffenberger, with a market cap of $391.4M.
Market Cap$391.4M
Employees165.0
CEOBrent Pfeiffenberger
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Century Therapeutics FAQ
Common questions about Century Therapeutics
Century Therapeutics (IPSC) has a market capitalization of $391.4M and trades on NASDAQ.
Century Therapeutics has approximately 165 employees.